We are going to be screening high risk but asymptomatic patients in Houston as part of a research study. We need a couple of people with knowledge of liver disease to explain things to patients taking part. We plan to start October 1st and run for 3 months.
Any liver transplant folks in Houston... - Living with Fatty...
Any liver transplant folks in Houston who would like to help educate people as part of a screening project for undiagnosed liver disease?
Written by
nash2
Partner
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Should nonalcoholic be removed from the name of fatty liver disease, do you have an opinion, would you like to participate in the decision?
AASLD has contacted the patient community through GLI about participating in a NAFLD nomenclature...
NASH radio tour results, part of our efforts to educate people about this disease so that it isn't such a silent unknown killer.
Early audience results are in from the 17 station interview tour we did a couple of weeks ago. I am...
One of the groups most at risk of liver disease is long haul truckers. We have joined with the HTAA to help educate them about health risks
We are working with the Healthy Trucking Association of America, (HTAA) to help educate and support...
Would you consider being in a clinical trial? Are you aware that without trials there is no hope of getting any treatment for NASH?
Why should any of us volunteer to do an educational video or be an advocate about liver disease?...
I need help from a few NAFLD/NASH patients who are willing to tell their stories and perhaps participate in a panel discussion.
I think you probably know that Madrigal is likely to have the first drug approved to treat...
Related Posts
Will You Take Our Survey Seeking NAFLD/NASH Patient Voices?- I'm surprised to be nominated for this award program
- Health in the land of unintended consequences. Do you know about the risks of dietary supplements?
- I'm surprised that no one has any issues with the way liver patients are treated. I didn't think I was the only one.
- Latest data on Resmetirom is published, FDA approval is expected in March
